Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,501.65 0.00 0.00%
S&P 500 1,878.61 3.22 0.17%
NASDAQ 4,148.34 21.37 0.52%
Ticker Volume Price Price Delta
STOXX 50 3,189.81 13.84 0.44%
FTSE 100 6,703.00 28.26 0.42%
DAX 9,548.68 4.49 0.05%
Ticker Volume Price Price Delta
NIKKEI 14,503.40 98.41 0.68%
TOPIX 1,174.95 10.05 0.86%
HANG SENG 22,562.80 53.16 0.24%

Astellas Joins the National Pharmaceutical Council



              Astellas Joins the National Pharmaceutical Council

PR Newswire

WASHINGTON, May 14, 2013

WASHINGTON, May 14, 2013 /PRNewswire-USNewswire/ -- The National
Pharmaceutical Council (NPC) today announced that Astellas Scientific and
Medical Affairs, Inc. (Astellas), a U.S. affiliate of Tokyo-based Astellas
Pharma Inc., has joined the health policy research organization as its newest
member.  

Located in Northbrook, Illinois, Astellas is a pharmaceutical company
dedicated to improving the health of people around the world through the
provision of innovative and reliable pharmaceutical products. Jeffrey Bloss,
M.D., vice president, scientific and medical affairs, will be the company's
representative on the NPC board of directors.

"We welcome Dr. Bloss to our board of directors and are looking forward to
Astellas' participation in NPC's activities," said NPC President Dan Leonard.
"Their perspective will be an invaluable resource for NPC as we continue our
mission to educate decision-makers about the tremendous value that the
biopharmaceutical industry adds to the health and well-being of Americans."

NPC is actively engaged in conducting health care policy research on topics
such as the challenges of individual patient treatment effects, the
utilization of real-world evidence and comparative effectiveness research, and
understanding the role and value of pharmaceuticals within the current and
evolving payment and delivery models.

"We are at an important time of great change with a new health care law, the
increasing individualization of drug treatments, and a change in the
conversation about those treatments. I look forward to working with NPC as it
meets these challenges," said Dr. Bloss. "The biopharmaceutical industry has
such an important story to tell, so it is a critical time to be involved with
NPC."

About the National Pharmaceutical Council:

The National Pharmaceutical Council is a health policy research organization
dedicated to the advancement of good evidence and science, and to fostering an
environment in the United Sates that supports medical innovation.  Founded in
1953 and supported by the nation's major research-based pharmaceutical
companies, NPC focuses on research development, information dissemination, and
education on the critical issues of evidence, innovation and the value of
medicines for patients.  For more information visit www.npcnow.org and follow
NPC on Twitter @npcnow.

SOURCE National Pharmaceutical Council

Website: http://www.npcnow.org
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement